Independent Research on Mutual Funds, Stocks & IPOs for Indian Investors

Molbio Diagnostics Limited, incorporated October 2000 and based in Goa, is a global point-of-care (POC) molecular diagnostics company. Proprietary 'Truenat' platform is a portable, battery-operated PCR-based molecular diagnostics system, patented in 100+ countries; its TB test is WHO-recommended. Backed by Temasek and Motilal Oswal. Revenue Rs 1,445.7 Cr (FY26) vs Rs 1,027.94 Cr (FY25), +41.7%; PAT Rs 166.6 Cr, +14.8%. Issue: fresh Rs 200 Cr + OFS Rs 739.70 Cr. Raised Rs 281.5 Cr from anchor investors incl. Goldman Sachs, BlackRock, Mirae Asset, Kotak MF, Tata MF, WhiteOak Capital. Final subscription: 70.26x overall (QIB 186.39x, NII 49.80x, RII 12.96x). Listed Aug 17, 2026 on BSE & NSE at Rs 980, up 21.44%.